- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Cobimetinib + vemurafenib – March 2016
Cobimetinib + vemurafenib: cobimetinib 20 mg tablet, 63 + vemurafenib 240 mg tablet, 56, Cotellic® Zelboraf®
Last updated
1 July 2016